$VRHI Open Market Transactions (Officer) https:
Post# of 25822
(Total Views: 37)
Posted On: 10/02/2025 9:26:50 AM
$VRHI Open Market Transactions (Officer)
https://www.otcmarkets.com/stock/VRHI/news/Op...?id=494466
VERI MEDTECH (VRHI) Announces Officer Purchases: 5,660 Additional Shares of VRHI Stock in Open Market Transactions
NEW YORK, October 2, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"
, healthcare technology platform, announced today that via open market transactions: Sam Adetunji, CEO, completed the additional purchase of 5,660 shares of VRHI stock at an average price per share of $1.45 for an aggregate total of 14,410 VRHI shares repurchased by Mr. Adetunji. As a result of these purchases, Mr. Adetunji beneficially owns: 7,650,545 shares of VRHI stock.
“Veri Medtech (VRHI) recently completed comprehensive PCAOB audits for fiscal years 2024 and 2023. This key accomplishment is a critical step in the company’s previously announced strategic focus, plans, and active efforts to seek uplisting to a senior stock exchange, which the company anticipates will help to further market leadership, buttress accretive acquisitions in healthcare technology and accelerate expansion of VRHI’s investor/shareholder base worldwide. There is more news to come,” said Sam Adetunji, CEO, Veri Medtech (VRHI).
https://www.otcmarkets.com/stock/VRHI/news/Op...?id=494466
VERI MEDTECH (VRHI) Announces Officer Purchases: 5,660 Additional Shares of VRHI Stock in Open Market Transactions
NEW YORK, October 2, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"
, healthcare technology platform, announced today that via open market transactions: Sam Adetunji, CEO, completed the additional purchase of 5,660 shares of VRHI stock at an average price per share of $1.45 for an aggregate total of 14,410 VRHI shares repurchased by Mr. Adetunji. As a result of these purchases, Mr. Adetunji beneficially owns: 7,650,545 shares of VRHI stock. “Veri Medtech (VRHI) recently completed comprehensive PCAOB audits for fiscal years 2024 and 2023. This key accomplishment is a critical step in the company’s previously announced strategic focus, plans, and active efforts to seek uplisting to a senior stock exchange, which the company anticipates will help to further market leadership, buttress accretive acquisitions in healthcare technology and accelerate expansion of VRHI’s investor/shareholder base worldwide. There is more news to come,” said Sam Adetunji, CEO, Veri Medtech (VRHI).
(0)
(0)